Carlsmed, Inc.
CARL
$13.74
$0.141.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Revenue | 12.08M | 10.19M | 6.08M | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 12.08M | 10.19M | 6.08M | ||
| Cost of Revenue | 3.21M | 2.55M | 1.52M | ||
| Gross Profit | 8.87M | 7.64M | 4.56M | ||
| SG&A Expenses | 11.21M | 10.21M | 6.88M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 18.59M | 15.91M | 12.40M | ||
| Operating Income | -6.50M | -5.72M | -6.32M | ||
| Income Before Tax | -6.77M | -5.73M | -6.28M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -6.77M | -5.73M | -6.28M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -6.77M | -5.73M | -6.28M | ||
| EBIT | -6.50M | -5.72M | -6.32M | ||
| EBITDA | -6.44M | -5.68M | -6.28M | ||
| EPS Basic | -1.47 | -1.47 | -1.55 | ||
| Normalized Basic EPS | -0.92 | -0.83 | -0.97 | ||
| EPS Diluted | -1.47 | -1.47 | -1.55 | ||
| Normalized Diluted EPS | -0.92 | -0.83 | -0.97 | ||
| Average Basic Shares Outstanding | 4.59M | 4.30M | 4.05M | ||
| Average Diluted Shares Outstanding | 4.59M | 4.30M | 4.05M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||